Paper35004331
The Role of Sphingolipids Metabolism in Cancer Drug Resistance.
Bataller M and 5 others. Front Oncol, 2021. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Role of Sphingolipids Metabolism in Cancer Drug Resistance. Papers, record 35004331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35004331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References122
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9813079 | Differential effects of sphingomyelin hydrolysis and cholesterol transport on oxysterol-binding protein phosphorylation and Golgi localization. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9813079 | PubMed |
| 2 | 25320006 | Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy. | Cancer Res | 2014 | https://conductscience.org/library/papers/25320006 | PubMed |
| 3 | 34516706 | Crucial role of glucosylceramide synthase in the regulation of stem cell-like cancer cells in B16F10 murine melanoma. | Mol Carcinog | 2021 | https://conductscience.org/library/papers/34516706 | PubMed |
| 4 | 14689449 | Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. | J Neurosci Res | 2004 | https://conductscience.org/library/papers/14689449 | PubMed |
| 5 | 21527515 | Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. | Blood | 2011 | https://conductscience.org/library/papers/21527515 | PubMed |
| 6 | 19521959 | Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. | Int J Cancer | 2009 | https://conductscience.org/library/papers/19521959 | PubMed |
| 7 | 18058224 | Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. | Breast Cancer Res Treat | 2008 | https://conductscience.org/library/papers/18058224 | PubMed |
| 8 | 12401200 | Sphingomyelinases: enzymology and membrane activity. | FEBS Lett | 2002 | https://conductscience.org/library/papers/12401200 | PubMed |
| 9 | 22074005 | Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer. | J Proteome Res | 2012 | https://conductscience.org/library/papers/22074005 | PubMed |
| 10 | 29348854 | Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency. | Oncotarget | 2017 | https://conductscience.org/library/papers/29348854 | PubMed |
| 11 | 28445970 | Acid ceramidase is a novel drug target for pediatric brain tumors. | Oncotarget | 2017 | https://conductscience.org/library/papers/28445970 | PubMed |
| 12 | 11114522 | An oncogenic role of sphingosine kinase. | Curr Biol | 2000 | https://conductscience.org/library/papers/11114522 | PubMed |
| 13 | 8379450 | Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. | Adv Lipid Res | 1993 | https://conductscience.org/library/papers/8379450 | PubMed |
| 14 | 25763355 | Phenotype switching in melanoma: implications for progression and therapy. | Front Oncol | 2015 | https://conductscience.org/library/papers/25763355 | PubMed |
| 15 | 29071215 | The Different Mechanisms of Cancer Drug Resistance: A Brief Review. | Adv Pharm Bull | 2017 | https://conductscience.org/library/papers/29071215 | PubMed |
| 16 | 27107419 | Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin. | Oncotarget | 2016 | https://conductscience.org/library/papers/27107419 | PubMed |
| 17 | 23864953 | Drug resistance and the role of combination chemotherapy in improving patient outcomes. | Int J Breast Cancer | 2013 | https://conductscience.org/library/papers/23864953 | PubMed |
| 18 | 16118219 | SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16118219 | PubMed |
| 19 | 15141021 | Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. | Mol Cancer Ther | 2004 | https://conductscience.org/library/papers/15141021 | PubMed |
| 20 | 30043096 | Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors. | Breast Cancer Res Treat | 2018 | https://conductscience.org/library/papers/30043096 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42783271 | Function of HIF-1α in Regulating Sphingolipid Metabolism and Alleviating Oxidative Stress Damage in Callosobruchus chinensis Under Hypoxia. | Insects | 2026 | https://conductscience.org/library/papers/42783271 | PubMed |
| 42151473 | Spatial lipidomics with in situ segmentation for profiling doxorubicin drug effect of hepatoma carcinoma cell spheroids. | Anal Bioanal Chem | 2026 | https://conductscience.org/library/papers/42151473 | PubMed |
| 42004813 | A Rare Case Report of Immunoglobulin D Subtype Multiple Myeloma Complicated With Hyperlipidemia. | Case Rep Hematol | 2026 | https://conductscience.org/library/papers/42004813 | PubMed |
| 41977417 | Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977417 | PubMed |
| 41929516 | Sphingolipid-associated signature unveils TIMP1-driven temozolomide resistance and guides stratified therapy in glioblastoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/41929516 | PubMed |
| 41795144 | SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/41795144 | PubMed |
| 41415282 | Development and validation of a machine learning-driven mitochondrial gene signature for the diagnosis of breast cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/41415282 | PubMed |
| 41372954 | Heterogeneity of common carotid artery and abdominal aorta: an angle of sphingolipid metabolism in vascular smooth muscle cells. | Biomed Eng Online | 2025 | https://conductscience.org/library/papers/41372954 | PubMed |
| 41293266 | Multiomics analyses of human colorectal cancer reveal changes in mitochondrial metabolism associated with chemotherapy resistance. | Front Oncol | 2025 | https://conductscience.org/library/papers/41293266 | PubMed |
| 41190221 | Sphingolipid Metabolism Dysregulation Drives Immune Microenvironment Remodeling and Predicts Prognosis in Bladder Cancer. | Int J Genomics | 2025 | https://conductscience.org/library/papers/41190221 | PubMed |
| 40703332 | Nrf1 acts as a highly-conserved determinon for maintaining robust redox homeostasis in the eco-evo-devo process of life histories. | Cell Stress | 2025 | https://conductscience.org/library/papers/40703332 | PubMed |
| 40429618 | Differential Effects of Sphingolipids on Cell Death and Antioxidant Defenses in Type 1 and Type 2 Endometrial Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429618 | PubMed |
| 40408281 | Cholangiocarcinoma cells direct fatty acids to support membrane synthesis and modulate macrophage phenotype. | Hepatol Commun | 2025 | https://conductscience.org/library/papers/40408281 | PubMed |
| 40332322 | Drug Resistance: The Role of Sphingolipid Metabolism. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332322 | PubMed |
| 40209098 | Impact of Excess Activin A on the Lipids, Metabolites, and Steroids of Adult Mouse Reproductive Organs. | Endocrinology | 2025 | https://conductscience.org/library/papers/40209098 | PubMed |
| 40088396 | Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/40088396 | PubMed |
| 39940937 | Identification of Lipid Species Signatures in FOLFOXIRI-Resistant Colorectal Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39940937 | PubMed |
| 39875359 | SPHK1 enhances olaparib resistance in ovarian cancer through the NFκB/NRF2/ferroptosis pathway. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/39875359 | PubMed |
| 39796160 | Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39796160 | PubMed |
| 39468100 | Leveraging ML for profiling lipidomic alterations in breast cancer tissues: a methodological perspective. | Sci Rep | 2024 | https://conductscience.org/library/papers/39468100 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35004331
GET https://conductscience.org/api/papers/v1/35004331/references?page=2